Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development

被引:184
作者
Axten, Jeffrey M. [1 ]
Romeril, Stuart P. [1 ]
Shu, Arthur [1 ]
Ralph, Jeffrey [1 ]
Medina, Jesus R. [1 ]
Feng, Yanhong [1 ]
Li, William Hoi Hong [1 ]
Grant, Seth W. [1 ]
Heerding, Dirk A. [1 ]
Minthorn, Elisabeth [1 ]
Mencken, Thomas [1 ]
Gaul, Nathan [2 ]
Goetz, Aaron [3 ]
Stanley, Thomas [3 ]
Hassell, Annie M. [4 ]
Gampe, Robert T. [4 ]
Atkins, Charity [1 ]
Kumar, Rakesh [1 ]
机构
[1] GlaxoSmithKline Res & Dev Ltd, Oncol Res, Prot Dynam DPU, Collegeville, PA 19426 USA
[2] GlaxoSmithKline Res & Dev Ltd, Screening & Compound Profiling, Collegeville, PA 19426 USA
[3] GlaxoSmithKline Res & Dev Ltd, Screening & Compound Profiling, Res Triangle Pk, NC 27713 USA
[4] GlaxoSmithKline Res & Dev Ltd, Biomol Struct Computat & Struct Chem, Res Triangle Pk, NC 27709 USA
关键词
PERK; UPR; kinase; lead optimization; structure-activity relationship; fluorine interaction; UNFOLDED PROTEIN RESPONSE; TRANSLATIONAL CONTROL; KINASE PERK; STRESS; PANCREAS; FLUORINE; PATHWAY; GROWTH;
D O I
10.1021/ml400228e
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
We recently reported the discovery of GSK2606414 (1), a selective first in class inhibitor of protein kinase R (PKR)-like endoplasrnic reticulum kinase (PERK), which inhibited PERK activation in cells and demonstrated tumor growth inhibition in a human tumor xenograft in mice. In continuation of our drug discovery program, we applied a strategy to decrease inhibitor lipophilicity as a means to improve physical properties and pharmacokinetics. This report describes our medicinal chemistry optimization culminating in the discovery of the PERK inhibitor GSK2656157 (6), which was selected for advancement to preclinical development.
引用
收藏
页码:964 / 968
页数:5
相关论文
共 20 条
[1]
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity [J].
Atkins, Charity ;
Liu, Qi ;
Minthorn, Elisabeth ;
Zhang, Shu-Yun ;
Figueroa, David J. ;
Moss, Katherine ;
Stanley, Thomas B. ;
Sanders, Brent ;
Goetz, Aaron ;
Gaul, Nathan ;
Choudhry, Anthony E. ;
Alsaid, Hasan ;
Jucker, Beat M. ;
Axten, Jeffrey M. ;
Kumar, Rakesh .
CANCER RESEARCH, 2013, 73 (06) :1993-2002
[2]
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) [J].
Axten, Jeffrey M. ;
Medina, Jesus R. ;
Feng, Yanhong ;
Shu, Arthur ;
Romeril, Stuart P. ;
Grant, Seth W. ;
Li, William Hoi Hong ;
Heerding, Dirk A. ;
Minthorn, Elisabeth ;
Mencken, Thomas ;
Atkins, Charity ;
Liu, Qi ;
Rabindran, Sridhar ;
Kumar, Rakesh ;
Hong, Xuan ;
Goetz, Aaron ;
Stanley, Thomas ;
Taylor, J. David ;
Sigethy, Scott D. ;
Tomberlin, Ginger H. ;
Hassell, Annie M. ;
Kahler, Kirsten M. ;
Shewchuk, Lisa M. ;
Gampe, Robert T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7193-7207
[3]
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth [J].
Bi, MX ;
Naczki, C ;
Koritzinsky, M ;
Fels, D ;
Blais, J ;
Hu, NP ;
Harding, H ;
Novoa, I ;
Varia, M ;
Raleigh, J ;
Scheuner, D ;
Kaufman, RJ ;
Bell, J ;
Ron, D ;
Wouters, BG ;
Koumenis, C .
EMBO JOURNAL, 2005, 24 (19) :3470-3481
[4]
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress [J].
Blais, Jaime D. ;
Addison, Christina L. ;
Edge, Robert ;
Falls, Theresa ;
Zhao, Huijun ;
Wary, Kishore ;
Koumenis, Costas ;
Harding, Heather P. ;
Ron, David ;
Holcik, Martin ;
Bell, John C. .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (24) :9517-9532
[5]
PERK Is Required in the Adult Pancreas and Is Essential for Maintenance of Glucose Homeostasis [J].
Gao, Yan ;
Sartori, Daniel J. ;
Li, Changhong ;
Yu, Qian-Chun ;
Kushner, Jake A. ;
Simon, M. Celeste ;
Diehl, J. Alan .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (24) :5129-5139
[6]
Transcriptional Regulation of VEGF-A by the Unfolded Protein Response Pathway [J].
Ghosh, Rajarshi ;
Lipson, Kathryn L. ;
Sargent, Karen E. ;
Mercurio, Arthur M. ;
Hunt, Joan S. ;
Ron, David ;
Urano, Fumihiko .
PLOS ONE, 2010, 5 (03) :A104-A115
[7]
Diabetes mellitus and exocrine pancreatic dysfunction in Perk-/- mice reveals a role for translational control in secretory cell survival [J].
Harding, HP ;
Zeng, HQ ;
Zhang, YH ;
Jungries, R ;
Chung, P ;
Plesken, H ;
Sabatini, DD ;
Ron, D .
MOLECULAR CELL, 2001, 7 (06) :1153-1163
[8]
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase [J].
Harding, HP ;
Zhang, YH ;
Ron, D .
NATURE, 1999, 397 (6716) :271-274
[9]
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities [J].
Kim, Inki ;
Xu, Wenjie ;
Reed, John C. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :1013-1030
[10]
Activation-dependent substrate recruitment by the eukaryotic translation initiation factor 2 kinase PERK [J].
Marciniak, SJ ;
Garcia-Bonilla, L ;
Hu, JJ ;
Harding, HP ;
Ron, D .
JOURNAL OF CELL BIOLOGY, 2006, 172 (02) :201-209